Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXŘ&Xxxxxx;XXX&Xxxxxx; XXXXXX (XX) č. 944/2013

xx xxx 2. ř&xxxxxx;xxx 2013,

xxxx&xxxxxx;x xx xxx &xxxxxx;čxxx xřxxxůxxxxx&xxxxxx; xěxxxxxxxxxxxxx&xxxxxx;xx pokroku xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 o klasifikaci, označování x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;

(Xxxx x x&xxxxxx;xxxxxx pro XXX)

XXXXXXX&Xxxxxx; XXXXXX,

x xxxxxxx xx Smlouvu x xxxxxx&xxxxxx;x&xxxxxx; Xxxxxxx&xxxxxx; xxxx,

x xxxxxxx xx xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx parlamentu x Xxxx (XX) č. 1272/2008 ze xxx 16. xxxxxxxx 2008 x xxxxxxxxxxx, označování x xxxxx&xxxxxx; x&xxxxxx;xxx x xxěx&xxxxxx;, o xxěxě a zrušení xxěxxxx 67/548/XXX x 1999/45/XX x x xxěxě xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1907/2006 (1), a xxxx&xxxxxx;xx xx čx. 37 odst. 5 x čx&xxxxxx;xxx 53 xxxxxx&xxxxxx;xx nařízení,

xxxxxxxx x xěxxx xůxxxůx:

(1)

Xxxxx xxx x pokyny xxx xxxxxčx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; X210 xxxxxxxx&xxxxxx; v xxxxxxx 6.2 části 1 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xx&xxxxxx;xx v x&xxxxxx;xxx x&xxxxxx;x&xxxxxx; revize Xxxx&xxxxxx;xxě xxxxxxxxxxxx&xxxxxx;xx xxxx&xxxxxx;xx klasifikace x xxxxčxx&xxxxxx;x&xxxxxx; xxxxxxx&xxxxxx;xx x&xxxxxx;xxx OSN (x&xxxxxx;xx xxx &xxxxx;XXX&xxxxx;) ke xxěx&xxxxxx;x, xxž xxxxxx x xxř&xxxxxx;xxx&xxxxxx; Xxxxxx (XX) č. 487/2013 (2) x xxx&xxxxxx; x&xxxxxx;řx xxxxxxxěxx. X zájmu xxxxxžxxxxx xx nezbytné xxxxxxxx mezi GHS x xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 xxx&xxxxxx; xxxxxx.

(2)

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008 xxxxxxxx xxx xxxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx látek. X xxxxxxx 3.1 je xxxxxx xxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; x xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x č&xxxxxx;xxxxx 2 xž 5 xř&xxxxxx;xxxx X nařízení (ES) č. 1272/2008. X xxxxxxx 3.2 je xxxxxx seznam xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx na x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x příloze XX xxěxxxxx Xxxx 67/548/EHS xx xxx 27. čxxxxx 1967 o xxxxžxx&xxxxxx;x&xxxxxx; xx&xxxxxx;xx&xxxxxx;xx x xxx&xxxxxx;xx&xxxxxx;xx xřxxxxxů x&xxxxxx;xxx&xxxxxx;x&xxxxxx;xx xx klasifikace, xxxxx&xxxxxx; x xxxxčxx&xxxxxx;x&xxxxxx; nebezpečných x&xxxxxx;xxx (3). Tyto xxx xxxxxxx xx xxxx&xxxxxx; xxěxxx, aby xx xxxx byly xxxxxxxx xxxxxxxxxxxx&xxxxxx; klasifikace látek, xx které xx xxž vztahuje xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx, a xxx xxxxxxxxxx i xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx.

(3)

X&xxxxxx;xxx pro xxxxxxx&xxxxxx;x&xxxxxx; xxxxx (RAC) Xxxxxxx&xxxxxx; xxxxxxxx pro xxxxxxx&xxxxxx; x&xxxxxx;xxx (XXXX) xxxxx xxxxxxxxxx x x&xxxxxx;xxxůx harmonizované klasifikace x xxxxčxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxx, xxxx&xxxxxx; xxxx xřxxxxžxxx xxxxxxřx x xxxxxxx x čx&xxxxxx;xxxx 37 xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008. Na x&xxxxxx;xxxxě xěxxxx xxxxxxxxxx x xx x&xxxxxx;xxxxě xřxxxx&xxxxxx;xxx xxxxžxx&xxxxxx;xx od dotčených xxxxx xx xřxxx xxěxxx xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, aby xxxx xxxxžxxx xxxxxxxxxxx xxxxxxxxxxx x označování xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(4)

Xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx stanovené x č&xxxxxx;xxx 3 xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, xx xx xxxěxx xxxž&xxxxxx;x xxxxxxxxřxxxě, xxxxť hospodářské xxxxxxxx xxxxx xxxřxxxxxx xxčxx&xxxxxx; xxxxx&xxxxxx; na xx, xxx mohly xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x xřxxxůxxxxx označování x xxxxx&xxxxxx; x&xxxxxx;xxx x xxěx&xxxxxx; x xxxxxx existující zásoby. Xxxxxx&xxxxxx;řxx&xxxxxx; xxxxxxxx xxxxx xxxxě xxxx xxxřxxxxxx xxčxx&xxxxxx; časové xxxxx&xxxxxx; xx xx, aby xxxxx xxxxxx povinnosti xxx registraci, které xxxx&xxxxxx;xxx&xxxxxx; x xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; látek xxxxxxxxxxxx&xxxxxx;xx xxxx karcinogenní, xxxxxxxx&xxxxxx; xxxx xxxxxx&xxxxxx; xxx xxxxxxxxxx, xxxxxxxx&xxxxxx; 1X a 1X (xxxxxxx 3.1) a xxxxxxxx&xxxxxx; 1 x 2 (xxxxxxx 3.2) xxxx xxxx xxxxxx xxxxxx&xxxxxx; xxx xxxx&xxxxxx; xxxxxxxxx x možností xxxxxxx xxxxxxxxx&xxxxxx; nepříznivé &xxxxxx;čxxxx xx xxxx&xxxxxx;x xxxxxřxx&xxxxxx;, xxxx&xxxxxx;xx xxx xxxxxxxxxx stanovené x čx&xxxxxx;xxx 23 nařízení Xxxxxxx&xxxxxx;xx parlamentu x Xxxx (XX) č. 1907/2006 ze xxx 18. prosince 2006 x registraci, hodnocení, xxxxxxx&xxxxxx;x&xxxxxx; a xxxxxx&xxxxxx;x&xxxxxx; xxxxxxx&xxxxxx;xx látek, o xř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx; xxxxxxxx xxx xxxxxxx&xxxxxx; x&xxxxxx;xxx, x xxěxě xxěxxxxx 1999/45/XX x x xxx&xxxxxx;xx&xxxxxx; nařízení Rady (XXX) č. 793/93, xxř&xxxxxx;xxx&xxxxxx; Xxxxxx (XX) č. 1488/94, xxěxxxxx Xxxx 76/769/EHS x xxěxxxx Xxxxxx 91/155/EHS, 93/67/XXX, 93/105/ES x 2000/21/XX (4).

(5)

Xxxxx xxx x x&xxxxxx;xxx &xxxxx;xxxxx, xxxx xxx, high-temp.“ (xxxxx, čxxxxxxxxx&xxxxxx; xxxxx, vysokoteplotní, č. XX: 266-028-2), xxxxxx&xxxxxx;řxx&xxxxxx; subjekty xxxxx xxxřxxxxxx delší čxxxx&xxxxxx; xxxxx&xxxxxx; xx xx, xxx xxxxx xxxxxx xxxxxxxxxx, xxxx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; x xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;xx xxxx xxxxxx xxxxxx&xxxxxx; xxx xxxx&xxxxxx; organismy x xxžxxxx&xxxxxx; xxxxxxx xxxxxxxxx&xxxxxx; xxxř&xxxxxx;xxxx&xxxxxx; účinky xx vodním xxxxxřxx&xxxxxx;, x xx zejména xxxxxxxxxx stanovené x čx&xxxxxx;xxx 3 a x xř&xxxxxx;xxxx III xxěxxxxx Xxxxxxx&xxxxxx;xx xxxxxxxxxx x Rady 2008/68/ES xx dne 24. x&xxxxxx;ř&xxxxxx; 2008 x xxxxxx&xxxxxx; přepravě xxxxxxxčx&xxxxxx;xx xěx&xxxxxx; (5). Xěxx by xxxxx x&xxxxxx;x xxxxxxxxx xxx&xxxxxx;&xxxxxx; xřxxxxxx&xxxxxx; xxxxx&xxxxxx;, xxž xx xxčxx xxxxxňxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx.

(6)

Xxxxx xxx x x&xxxxxx;xxx &xxxxx;xxxxxxx arsenide“ (xxxxxxx xxxxxx&xxxxxx;, č. XX: 215-114-8), výbor XXX xxxxxxxx&xxxxxx;x&xxxxxx; nové xxxxxxxxxx xxxxxxě xř&xxxxxx;xx nebezpečnosti &xxxxx;xxxxxxxx xxx xxxxxxxxxx&xxxxx;. Xxxx xř&xxxxxx;xx nebezpečnosti xx xx xxxxx xxxěxx zařazovat xx xř&xxxxxx;xxxx XX nařízení (XX) č. 1272/2008, xxxxx xxxx xxxxxxxxxx xxxxxx xxxxxčxxx.

(7)

Xxxxx jde x x&xxxxxx;xxx &xxxxx;xxxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxxxxxx&xxxxx; (polyhexamethylen-biguanid xxxxxxxxxxxx, č. CAS: 27083-27-8 nebo 32289-58-0), xxxx nyní k xxxxxxxxx xxx&xxxxxx; xěxxxx&xxxxxx; &xxxxxx;xxxx pro xř&xxxxxx;xx xxxxxxxčxxxxx &xxxxx;xxxxx&xxxxxx; xxxxxxxx (xxxxxxčx&xxxxxx;)&xxxxx;, xxž naznačuje, žx xxxxxxxxxxx pro xxxx xř&xxxxxx;xx xxxxxxxčxxxxx xxxxxxčxxxx&xxxxxx; xx stanovisku x&xxxxxx;xxxx XXX, xxž xx xxxx&xxxxxx;x&xxxxxx; na xxxx&xxxxxx;&xxxxxx;xx &xxxxxx;xxx&xxxxxx;xx, by xxxxxxxx x&xxxxxx;x přiměřená. Xxxx třída nebezpečnosti xx xx proto xxxěxx zařazovat xx xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxxx x&xxxxxx;xxx XXX xxxěx příležitost vydat xxxxxxxxxx x novým xxxxxxxx&xxxxxx;x, zatímco x&xxxxxx;xxxxx xxxxxx&xxxxxx; xř&xxxxxx;xx xxxxxxxčxxxxx xxxxžxx&xxxxxx; xx xxxxxxxxxx x&xxxxxx;xxxx RAC by xxřxxxxx x&xxxxxx;x xěxx.

(8)

X xxxxxxx x přechodnými xxxxxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, jež xxxžňxx&xxxxxx; použití nových xxxxxxxxx&xxxxxx; x předstihem xx x&xxxxxx;xx xxxxxxxxxxxxx, xx měli mít xxxxxxxxx&xxxxxx; xxžxxxx xxxž&xxxxxx;xxx xxxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxx x č&xxxxxx;xxx 3 xř&xxxxxx;xxxx XX nařízení (XX) č. 1272/2008, xx xxěx&xxxxxx; tohoto xxř&xxxxxx;xxx&xxxxxx;, a xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x balení xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x způsobem na xxxxxxxxx&xxxxxx; x&xxxxxx;xx xřxx xxxx, k xxxž xx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx xxxxxx xxxxxx&xxxxxx;xx.

(9)

Opatření xxxxxxxx&xxxxxx; x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x xxxx x souladu xx xxxxxxxxxxx výboru xř&xxxxxx;xxx&xxxxxx;xx xxxxx čx&xxxxxx;xxx 133 xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1907/2006,

XŘXXXXX XXXX NAŘÍZENÍ:

Čx&xxxxxx;xxx 1

Nařízení (XX) č. 1272/2008 se xěx&xxxxxx; takto:

1)

Příloha XX xx mění x xxxxxxx s xř&xxxxxx;xxxxx X tohoto xxř&xxxxxx;xxx&xxxxxx;.

2)

Č&xxxxxx;xx 3 přílohy XX xx xěx&xxxxxx; xxxxx:

x)

tabulka 3.1 xx xěx&xxxxxx; xxxxx:

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxx&xxxxxx; odpovídají x&xxxxxx;xxxxůx xxxxxx&xxxxxx;x v příloze XX tohoto xxř&xxxxxx;xxx&xxxxxx;, xx xxxxxxxx&xxxxxx; záznamy xxxxxx&xxxxxx;xx v xř&xxxxxx;xxxx XX tohoto nařízení,

xx)

záznamy xxxxxx&xxxxxx; x xř&xxxxxx;xxxx XXX xxxxxx xxř&xxxxxx;xxx&xxxxxx; xx xxx&xxxxxx;xxx&xxxxxx; v xxxxxxx x posloupností x&xxxxxx;xxxxů uvedených x xxxxxxx 3.1;

b)

tabulka 3.2 xx xěx&xxxxxx; xxxxx:

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x příloze XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, xxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx; x&xxxxxx;xxxxůx xxxxxx&xxxxxx;x x xř&xxxxxx;xxxx XX xxxxxx xxř&xxxxxx;xxx&xxxxxx;, xx xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx xxxxxx&xxxxxx;xx x příloze IV xxxxxx xxř&xxxxxx;xxx&xxxxxx;,

ii)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x xř&xxxxxx;xxxx X xxxxxx xxř&xxxxxx;xxx&xxxxxx; xx xxx&xxxxxx;xxx&xxxxxx; x xxxxxxx x xxxxxxxxxxx&xxxxxx; x&xxxxxx;xxxxů xxxxxx&xxxxxx;xx v xxxxxxx 3.2.

Čx&xxxxxx;xxx 2

1.&xxxx;&xxxx;&xxxx;Xxxxxxxě od čx. 3 odst. 2 xxxxx být x&xxxxxx;xxx a xxěxx xxxxxxxxxx&xxxxxx;xx, xxxxčxx&xxxxxx;xx x xxxxxx x souladu x nařízením (ES) č. 1272/2008 xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx; xřxx 1. prosincem 2014, xxxx. 1. čxxxxxx 2015.

2.   Odchylně xx čx. 3 odst. 2 xxxxx&xxxxxx; být x&xxxxxx;xxx klasifikované, xxxxčxxxx&xxxxxx; x balené x xxxxxxx s xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 x xx&xxxxxx;xěx&xxxxxx; xx xxx před 1. xxxxxxxxx 2014 znovu xxxxčxxx x xxxxxxxx x xxxxxxx x xxř&xxxxxx;xxx&xxxxxx;x (ES) č. 1272/2008 xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, x xx xž xx 1. xxxxxxxx 2016.

3.   Odchylně xx čx. 3 xxxx. 2 xxxxx&xxxxxx; x&xxxxxx;x směsi xxxxxxxxxxxx&xxxxxx;, xxxxčxxxx&xxxxxx; a xxxxx&xxxxxx; x souladu xx xxěxxxx&xxxxxx; Xxxxxxx&xxxxxx;xx parlamentu x Xxxx 1999/45/XX (6) xxxx xxř&xxxxxx;xxx&xxxxxx;x (ES) č. 1272/2008 x xxxxxx&xxxxxx; xx trh xřxx 1. čxxxxxx 2015 xxxxx označeny x xxxxxxxx x xxxxxxx x xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 xx znění xxxxxx xxř&xxxxxx;xxx&xxxxxx;, a xx xž do 1. čxxxxx 2017.

4.&xxxx;&xxxx;&xxxx;Xxxxxxxě xx čx. 3 odst. 3 lze xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx stanovené v č&xxxxxx;xxx 3 přílohy XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, ve xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, xxxž&xxxxxx;x xřxx xxxx xxxxxx&xxxxxx;xx x čx. 3 odst. 3.

Čx&xxxxxx;xxx 3

1.   Toto xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x platnost xxxx&xxxxxx;x&xxxxxx;x dnem po xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; x Úředním xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; xxxx.

2.&xxxx;&xxxx;&xxxx;Xxxxxxxxx&xxxxxx; čx. 1 xxxx. 1 se xxx x&xxxxxx;xxx použije od 1. xxxxxxxx 2014 x xxx směsi xx 1. čxxxxx 2015.

3.&xxxx;&xxxx;&xxxx;Xxxxxxxxx&xxxxxx; čx. 1 xxxx. 2 xx xxxžxx&xxxxxx; xxx xxx 1. ledna 2015 xxx všechny položky xxxxx xxxxžxx &xxxxx;xxxxx, xxxx xxx, xxxx-xxxx.&xxxxx; (xxxxx, černouhelný xxxxx, xxxxxxxxxxxxx&xxxxxx;, č. XX: 266-028-2), xxx xxxxxx xx čx&xxxxxx;xxx 1 xxxžxxx ode xxx 1. xxxxx 2016.

Xxxx xxř&xxxxxx;xxx&xxxxxx; je x&xxxxxx;xxxx&xxxxxx; x celém xxxxxxx x xř&xxxxxx;xx xxxžxxxxx&xxxxxx; xx x&xxxxxx;xxx čxxxxx&xxxxxx;xx xx&xxxxxx;xxxx.

X Bruselu xxx 2. ř&xxxxxx;xxx 2013.

Xx Komisi

Xxx&xxxxxx; Manuel XXXXXXX

xřxxxxxx

(1)&xxxx;&xxxx;&Xxxxxx;ř. věst. X 353, 31.12.2008, s. 1.

(2)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. L 149, 1.6.2013, x. 1.

(3)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. 196, 16.8.1967, x. 1.

(4)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. X 396, 30.12.2006, x. 1.

(5)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. X 260, 30.9.2008, x. 13.

(6)&xxxx;&xxxx;&Xxxxxx;ř. xěxx. L 200, 30.7.1999, s. 1.

XŘ&Xxxxxx;XXXX I

X č&xxxxxx;xxx 1 tabulce 6.2 xř&xxxxxx;xxxx IV nařízení (XX) č. 1272/2008 xx x&xxxxxx;x X210 xxxxxxxxx x&xxxxxx;xxx:

&xxxxx;X210

Chraňte před xxxxxx, xxxx&xxxxxx;xx xxxxxxx, xxxxxxxx, xxxxřxx&xxxxxx;x xxxxxxxx x jinými xxxxxx xxx&xxxxxx;xxx&xxxxxx;. X&xxxxxx;xxx kouření.

X&xxxxxx;xx&xxxxxx;xxxx (xxx&xxxxxx;x 2.1)

Xxxxř&xxxxxx;xx 1.1, 1.2, 1.3, 1.4, 1.5

&xxxx;

Xxřxxx&xxxxxx; plyny (xxx&xxxxxx;x 2.2)

1, 2

Aerosoly (xxx&xxxxxx;x 2.3)

1, 2, 3

Xxřxxx&xxxxxx; xxxxxxxx (xxx&xxxxxx;x 2.6)

1, 2, 3

Xxřxxx&xxxxxx; xxx&xxxxxx; x&xxxxxx;xxx (xxx&xxxxxx;x 2.7)

1, 2

Xxxxxxxxě xxxxxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxx x xxěxx (xxx&xxxxxx;x 2.8)

Xxxx A, B, X, D, X, X

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxx (xxx&xxxxxx;x 2.9)

1

Xxxxx&xxxxxx;xxxx&xxxxxx; xxx&xxxxxx; x&xxxxxx;xxx (xxx&xxxxxx;x 2.10)

1

Xxxxxx&xxxxxx;x&xxxxxx; xxxxxxxx (xxx&xxxxxx;x 2.13)

1, 2, 3

Xxxxxx&xxxxxx;x&xxxxxx; xxx&xxxxxx; x&xxxxxx;xxx (xxx&xxxxxx;x 2.14)

1, 2, 3

Xxxxxxxx&xxxxxx; xxxxxxxx (oddíl 2.15)

Xxxx X, B, X, X, E, X&xxxxx;

XŘ&Xxxxxx;XXXX XX

Xxxxxxx&xxxxxx; číslo

Mezinárodní xxxxxxxxxxxx xxxxxxx&xxxxxx;xx x&xxxxxx;xxx

Č&xxxxxx;xxx XX

Č&xxxxxx;xxx CAS

Xxxxxxxxxxx

Označení

Xxxxxxxxx&xxxxxx; koncent. xxxxxx,

xxxxxxxxxxčx&xxxxxx; xxxxxxx

Xxxx.

Kódy tříd x xxxxxxxx&xxxxxx; xxxxxxxčxxxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx o xxxxxxxčxxxxx

X&xxxxxx;xx x&xxxxxx;xxxxžx&xxxxxx;xx symbolů x xxxx&xxxxxx;xx&xxxxxx;xx xxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx vět o xxxxxxxčxxxxx

X&xxxxxx;xx xxxxň. xxxxxxxxx&xxxxxx;xx xěx o nebezpečnosti

015-004-00-8

xxxxxxxxx xxxxxxxxx

244-088-0

20859-73-8

Xxxxx-xxxxx. 1

H260

XXX02

X260

XXX029

M = 100

&xxxx;

Xxxxx Xxx. 2

H300

GHS06

X300

XXX032

&xxxx;

Xxxxx Xxx. 3

X311

XXX09

X311

 

Acute Tox. 1

X330

Xxx

X330

&xxxx;

Xxxxxxx Acute 1

X400

 

H400

&xxxx;

015-005-00-3

magnesium xxxxxxxxx;

xxxxxxxxxxxx xxxxxxxxxxx

235-023-7

12057-74-8

Xxxxx-xxxxx. 1

X260

GHS02

X260

XXX029

M = 100

 

Acute Xxx. 2

X300

XXX06

X300

XXX032

&xxxx;

Xxxxx Tox. 3

X311

GHS09

H311

 

Xxxxx Xxx. 1

X330

Xxx

X330

&xxxx;

Xxxxxxx Acute 1

X400

&xxxx;

X400

&xxxx;

015-123-00-5

xxxxxxxxxx (XXX);

xxxxx-4-xxxxxxxxxx-x-xxxxx xxxxxxxxx xxxxxxxxxxxxxxx

244-848-1

22224-92-6

Xxxxx Tox. 2

H300

GHS06

H300

&xxxx;

M = 100

M = 100

&xxxx;

Xxxxx Tox. 2

X310

XXX09

X310

Xxxxx Xxx. 2

X330

Dgr

X330

Eye Xxxxx. 2

X319

&xxxx;

X319

Xxxxxxx Acute 1

H400

 

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

030-012-00-1

xxxxxxxxx-xxxxxxxxx-xxxx-xxxxxxxxx-xxxxxxxxx

423-570-6

169314-88-9

Xxxxxxx Xxxxxxx 4

X413

&xxxx;

X413

&xxxx;

&xxxx;

&xxxx;

602-006-00-4

xxxxxxxxxx;

xxxxxxxxxxxxxxxx

200-663-8

67-66-3

Xxxx. 2

X351

XXX06

X351

&xxxx;

&xxxx;

 

Repr. 2

H361d

GHS08

H361d

Xxxxx Xxx. 3

X331

Xxx

X331

Xxxxx Xxx. 4

X302

&xxxx;

X302

XXXX XX 1

H372

&xxxx;

H372

Xxx Xxxxx. 2

X319

&xxxx;

X319

Xxxx Irrit. 2

X315

&xxxx;

X315

603-097-00-3

1,1&xxxxx;,1&xxxxx;-xxxxxxxxxxxxxxxx-2-xx;

xxxxxxxxxxxxxxxxxxx

204-528-4

122-20-3

Xxx Xxxxx. 2

X319

XXX07

Xxx

X319

&xxxx;

&xxxx;

&xxxx;

605-008-00-3

acrolein;

prop-2-enal;

acrylaldehyde

203-453-4

107-02-8

Xxxx. Xxx. 2

X225

XXX02

X225

XXX071

Skin Xxxx. 1; X314: X &xx; 0,1&xxxx;%

X

Acute Xxx. 1

X330

XXX06

X330

&xxxx;

Xxxxx Tox. 2

X300

GHS05

X300

 

Xxxxx Xxx. 3

H311

GHS09

X311

&xxxx;

Skin Xxxx. 1

X314

Xxx

X314

&xxxx;

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

 

X = 100

Xxxxxxx Chronic 1

X410

&xxxx;

X410

&xxxx;

X = 1

607-023-00-0

xxxxx xxxxxxx

203-545-4

108-05-4

Xxxx. Xxx. 2

X225

XXX02

H225

&xxxx;

&xxxx;

D

Carc. 2

X351

XXX08

X351

&xxxx;

&xxxx;

Xxxxx Tox. 4

X332

XXX07

X332

 

&xxxx;

STOT XX 3

X335

Xxx

X335

&xxxx;

 

607-613-00-8

reaction xxxx xx:

&xxxx;

xxxxxxxx xxxx

&xxxx;

xxxxxxxxxxxxxxx xxxx

&xxxx;

dipersuccinic xxxx

&xxxx;

xxxxxxxxxx xxxxx of xxxxxxxx acid

&xxxx;

xxxxxxxxxx xxxxx xx persuccinic xxxx

 

dimethyl xxxxxxxxx xxxxxxxx xxxx

 

xxxxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxxxxx xxxx

 

xxxxxxxxxx xxxxx xx glutaric xxxx

&xxxx;

xxxxxxxxxx xxxxx xx perglutaric xxxx

&xxxx;

xxxxxxxx glutarate xxxxxx xxxx

&xxxx;

xxxxxxxxxxxxx acid

 

xxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx of xxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx of xxxxxxxxx acid

 

xxxxxxxx xxxxxxx

&xxxx;

xxxxxxxx xxxxxxxx

&xxxx;

xxxxxxxx

&xxxx;

xxxxx

432-790-1

&xxxx;

Xxxxx Tox. 4*

H332

GHS07

H332

&xxxx;

&xxxx;

 

Xxxxx Xxx. 4*

X312

GHS05

X312

Xxxxx Xxx. 4*

X302

XXX08

X302

Xxxx Corr. 1X

X314

Xxx

H314

XXXX XX 2

X371 (eyes)

&xxxx;

X371 (xxxx)

609-003-00-7

xxxxxxxxxxxx

202-716-0

98-95-3

Xxxx. 2.

X351

XXX06

X351

 

 

 

Repr. 1X

H360F

XXX08

H360F

Xxxxx Xxx. 3

X301

Dgr

H301

Acute Xxx. 3

X331

&xxxx;

X331

Xxxxx Tox. 3

H311

&xxxx;

X311

XXXX XX 1

H372 (xxxxx)

 

X372 (xxxxx)

Xxxxxxx Xxxxxxx 3

H412

&xxxx;

X412

612-120-00-6

aclonifen (XXX);

2-xxxxxx-6-xxxxx-3-xxxxxxxxxxxxxx

277-704-1

74070-46-5

Xxxx. 2

X351

GHS08

X351

&xxxx;

X = 100

X = 10

 

Xxxx Xxxx. 1 X

H317

GHS07

X317

&xxxx;

Xxxxxxx Xxxxx 1

X400

XXX09

 

&xxxx;

Aquatic Chronic 1

X410

Xxx

X410

&xxxx;

613-175-00-9

xxxxxxxxxxxxx (ISO);

(2XX,3XX)-3-(2-xxxxxxxxxxxx)-2-(4-xxxxxxxxxxxx)-[( 1X-1,2,4-xxxxxxx-1-xx)xxxxxx]xxxxxxx

406-850-2

133855-98-8

Xxxx. 2

X351

XXX08

X351

&xxxx;

&xxxx;

&xxxx;

Xxxx. 1X

X360Xx

GHS09

X360Xx

Aquatic Chronic 2

X411

Xxx

X411

616-200-00-1

xxxxxxxx xxxx xx X,X&xxxxx;-xxxxxx-1,2-xxxxxxx(xxxxxxxxxx) xxx 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide xxx X,X&xxxxx;-xxxxxx-1,2-xxxxxxx(12-xxxxxxxxxxxxxxxx xxxxx)

432-430-3

&xxxx;

Aquatic Xxxxxxx 4

H413

 

H413

 

&xxxx;

&xxxx;

648-055-00-5

xxxxx, xxxx xxx, high-temp.;

[The xxxxxxx xxxx xxx distillation xx xxxx xxxxxxxxxxx xxxx xxx. A xxxxx xxxxx with xx xxxxxxxxxxx xxxxxxxxx xxxxx xxxx 30&xxxx;&xxx;X xx 180&xxxx;&xxx;X (86&xxxx;&xxx;X xx 356&xxxx;&xxx;X). Xxxxxxxx xxxxxxxxx xx a xxxxxxx mixture of xxxxx xx more xxxxxxxx xxxxxxxxx xxxx xxxxxxxx xxxxxxxxxxxx.]

266-028-2

65996-93-2

Xxxx. 1 X

X350

XXX08

X350

&xxxx;

X = 1000

X = 1000

&xxxx;

Xxxx. 1B

X340

XXX09

H340

&xxxx;

Repr. 1X

X360XX

Xxx

X360XX

&xxxx;

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

 

H410

&xxxx;

649-330-00-2

naphtha (xxxxxxxxx), xxxxxxxxxxxxxxxxxx heavy;

Low boiling xxxxx hydrogen treated xxxxxxx;

[X xxxxxxx xxxxxxxxxxx xx xxxxxxxxxxxx xxxxxxxx xxxx a xxxxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxx. It xxxxxxxx of hydrocarbons xxxxxx xxxxxx numbers xxxxxxxxxxxxx xx xxx xxxxx xx C7 xxxxxxx X12 xxx xxxxxxx in the xxxxx xx xxxxxxxxxxxxx 90&xxxx;&xxx;X to 230&xxxx;&xxx;X (194&xxxx;&xxx;X xx 446&xxxx;&xxx;X).]

265-185-4

64742-82-1

Carc. 1X

X350

XXX08

X350

&xxxx;

&xxxx;

X

Xxxx. 1X

H340

Xxx

H340

XXXX XX 1

X372 (xxxxxxx xxxxxxx xxxxxx)

&xxxx;

X372 (central nervous xxxxxx)

Xxx. Xxx. 1

X304

&xxxx;

X304

649-345-00-4

xxxxxxxx xxxxxxx;

Xxx boiling point xxxxxxx — xxxxxxxxxxx;

[A xxxxxxxxxx, xxxxxxx petroleum xxxxxxxxxx xxxx xx xxxx xxxx xxxxxx xx xxxxxxxxxxxxx xxxxxx xxx that xxxxx xx x xxxxx xx xxxxxxxxxxxxx 148,8 °C xx 204,4&xxxx;&xxx;X (300&xxxx;&xxx;X xx 400 °F).]

232-489-3

8052-41-3

Xxxx. 1X

H350

GHS08

H350

 

&xxxx;

P

Xxxx. 1X

X340

Xxx

X340

XXXX XX 1

X372 (xxxxxxx xxxxxxx system)

 

X372 (xxxxxxx xxxxxxx system)

Xxx. Xxx. 1

X304

&xxxx;

X304

649-405-00-X

solvent xxxxxxx (xxxxxxxxx), xxxxxx aliph.;

Xxxxxxxx xxx xxxxxxxx;

[X complex xxxxxxxxxxx xx hydrocarbons xxxxxxxx xxxx xxx xxxxxxxxxxxx xx xxxxx xxx xx natural xxxxxxxx. Xx xxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx having xxxxxx xxxxxxx predominantly in xxx xxxxx xx X9 xxxxxxx X12 xxx xxxxxxx xx xxx xxxxx xx xxxxxxxxxxxxx 140 °C xx 220&xxxx;&xxx;X (284&xxxx;&xxx;X xx 428&xxxx;&xxx;X).]

265-191-7

64742-88-7

XXXX XX 1

H372 (xxxxxxx xxxxxxx xxxxxx)

XXX08

X372 (xxxxxxx xxxxxxx xxxxxx)

&xxxx;

&xxxx;

&xxxx;

Xxx. Xxx. 1

H304

Dgr

H304

XŘ&Xxxxxx;XXXX XXX

Indexové č&xxxxxx;xxx

Mezinárodní xxxxxxxxxxxx chemických látek

Číslo XX

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxx&xxxxxx; xxxxxxx. xxxxxx,

xxxxxxxxxxčx&xxxxxx; xxxxxxx

Xxxx.

X&xxxxxx;xx tříd x xxxxxxxx&xxxxxx; xxxxxxxčxxxxx

Kódy xxxxxxxxx&xxxxxx;xx vět o xxxxxxxčxxxxx

X&xxxxxx;xx výstražných symbolů x xxxx&xxxxxx;xx&xxxxxx;xx xxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx vět o xxxxxxxčxxxxx

X&xxxxxx;xx xxxxň. xxxxxxxxx&xxxxxx;xx xěx x nebezpečnosti

031-001-00-4

xxxxxxx xxxxxxxx

215-114-8

1303-00-0

Xxxx. 1X

X350

XXX08

X350

&xxxx;

 

 

XXXX XX 1

X372 (respiratory xxx xxxxxxxxxxxxxx xxxxxxx)

Xxx

H372 (xxxxxxxxxxx xxx haematopoietic systems)

050-025-00-6

xxxxxxxxxxxxxxxxxxxxxxx

213-608-8

993-16-8

Xxxx. 2

X361x

XXX08

Xxx

X361x

&xxxx;

&xxxx;

&xxxx;

050-026-00-1

2-xxxxxxxxxx 10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

260-828-5

57583-34-3

Xxxx. 2

X361x

XXX08

Wng

H361d

&xxxx;

 

 

050-027-00-7

2-xxxxxxxxxx 10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

239-622-4

15571-58-1

Xxxx. 1B

X360X

XXX08

Dgr

X360X

 

&xxxx;

 

601-087-00-3

2,4,4-xxxxxxxxxxxxxxxx

246-690-9

25167-70-8

Flam. Liq. 2

X225

XXX02

X225

&xxxx;

&xxxx;

X

Xxx. Tox. 1

X304

GHS07

X304

STOT XX 3

X336

XXX08

Xxx

H336

606-145-00-1

sulcotrione (XXX);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

 

99105-77-8

Xxxx. 2

X361x

XXX08

X361x

&xxxx;

X = 1

X = 10

&xxxx;

XXXX XX 2

X373 (xxxxxxx)

XXX07

X373 (kidneys)

Xxxx Xxxx. 1 A

X317

GHS09

H317

Xxxxxxx Xxxxx 1

H400

Xxx

&xxxx;

Aquatic Xxxxxxx 1

X410

&xxxx;

X410

607-699-00-7

xxxxxxxxxx (ISO);

(2-xxxxxxxxxxxxxx-3-xx)xxxxxx xxx-(1X,3X)-3-[(1X)-2-xxxxxx-3,3,3-xxxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

&xxxx;

82657-04-3

Carc. 2

X351

XXX06

X351

&xxxx;

X = 10&xxxx;000

X = 100&xxxx;000

&xxxx;

Xxxxx Tox. 3

X331

XXX08

X331

Xxxxx Tox. 2

H300

GHS09

X300

XXXX XX 1

H372 (xxxxxxx xxxxxx)

Xxx

X372 (nervous system)

Xxxx Xxxx. 1X

X317

&xxxx;

X317

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

607-700-00-0

xxxxxxxxxx (XXX);

xxxxxx (4xX)-7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx [1]

&xxxx;

173584-44-6 [1]

Xxxxx Xxx. 3

H301

XXX06

H301

&xxxx;

M = 1

X = 1

&xxxx;

Xxxxx Tox. 4

X332

GHS08

H332

STOT XX 1

X372 (xxxxx, xxxxxxx system, heart)

XXX09

X372 (xxxxx, nervous system, xxxxx)

Xxxx Sens. 1X

H317

Dgr

X317

Aquatic Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

xxxxxxxx mass of (X)- Xxxxxxxxxx xxx (X)- Indoxacarb 75:25;

xxxxxx 7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx [2]

144171-61-9 [2]

&xxxx;

&xxxx;

&xxxx;

&xxxx;

607-702-00-1

xxxxxxx xxxxxxxxx

201-559-5

84-75-3

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX

 

&xxxx;

&xxxx;

607-703-00-7

xxxxxxxxxxxxxxxxx- fluorooctanoate

223-320-4

3825-26-1

Xxxx. 2

X351

XXX08

X351

&xxxx;

&xxxx;

&xxxx;

Xxxx. 1X

H360D

XXX07

X360X

Xxxx.

X362

XXX05

H362

Xxxxx Xxx. 4

X332

Xxx

X332

Xxxxx Xxx. 4

X302

 

H302

XXXX XX 1

H372 (xxxxx)

&xxxx;

X372 (xxxxx)

Xxx Xxx.1

X318

&xxxx;

X318

607-704-00-2

xxxxxxxxxxxxxxxxx xxxx

206-397-9

335-67-1

Xxxx. 2

X351

XXX08

X351

&xxxx;

&xxxx;

&xxxx;

Xxxx. 1X

X360X

GHS07

X360X

Xxxx.

X362

GHS05

H362

Xxxxx Xxx. 4

X332

Xxx

X332

Xxxxx Tox. 4

X302

&xxxx;

X302

STOT XX 1

X372 (liver)

&xxxx;

H372 (xxxxx)

Xxx Xxx. 1

H318

 

H318

612-282-00-8

xxxxxxxxxxxxxx

204-695-3

124-30-1

Xxx. Xxx. 1

H304

XXX05

X304

&xxxx;

X = 10

X = 10

&xxxx;

STOT XX 2

X373 (xxxxxx-xxxxxxxxxx xxxxx, liver, xxxxxx xxxxxx)

XXX08

X373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, xxxxxx xxxxxx)

Skin Xxxxx. 2

X315

GHS09

H315

Eye Xxx. 1

X318

Xxx

X318

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

H410

&xxxx;

X410

612-283-00-3

(X)-xxxxxxx-9-xxxxxxxxx

204-015-5

112-90-3

Acute Xxx. 4

X302

XXX05

X302

&xxxx;

X = 10

X = 10

 

Xxx Xxx. 1

X304

XXX07

X304

XXXX XX 3

H335

GHS08

X335

STOT XX 2

X373 (xxxxxx-xxxxxxxxxx xxxxx, liver, immune xxxxxx)

XXX09

X373 (gastro-intestinal tract, xxxxx, xxxxxx xxxxxx)

Xxxx Xxxx. 1X

X314

Dgr

X314

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

H410

&xxxx;

X410

612-284-00-9

amines, xxxxxxxxxxxx xxxxxx xxxxx

262-976-6

61788-45-2

Asp Xxx. 1

X304

XXX08

X304

&xxxx;

M = 10

X = 10

&xxxx;

XXXX XX 2

X373 (gastro-intestinal xxxxx, xxxxx, xxxxxx xxxxxx)

XXX05

X373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, xxxxxx xxxxxx)

Xxxx Xxxxx. 2

H315

XXX09

X315

Eye Xxx. 1

X318

Xxx

X318

Xxxxxxx Xxxxx 1

H400

&xxxx;

 

Xxxxxxx Xxxxxxx 1

H410

 

H410

612-285-00-4

xxxxxx, xxxx xxxxx

262-977-1

61788-46-3

Xxxxx Xxx. 4

H302

GHS05

X302

 

M = 10

X = 10

&xxxx;

Xxx. Xxx. 1

X304

XXX07

X304

XXXX XX 3

H335

GHS08

X335

XXXX XX 2

X373 (gastro-intestinal xxxxx, xxxxx, xxxxxx xxxxxx)

GHS09

X373 (xxxxxx-xxxxxxxxxx tract, xxxxx, xxxxxx xxxxxx)

Xxxx Corr. 1X

X314

Xxx

X314

Xxxxxxx Xxxxx 1

X400

&xxxx;

&xxxx;

Aquatic Xxxxxxx 1

X410

&xxxx;

X410

612-286-00-X

amines, xxxxxx xxxxx

263-125-1

61790-33-8

Xxxxx Xxx. 4

H302

XXX05

X302

 

M = 10

X = 10

&xxxx;

Xxx. Xxx. 1

X304

GHS07

X304

XXXX XX 2

H373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, xxxxxx xxxxxx)

XXX08

X373 (xxxxxx-xxxxxxxxxx xxxxx, xxxxx, immune xxxxxx)

Xxxx Xxxx. 1X

X314

GHS09

H314

Xxxxxxx Xxxxx 1

X400

Xxx

&xxxx;

Xxxxxxx Chronic 1

X410

 

X410

616-206-00-4

flufenoxuron (XXX);

1-(4-(2-xxxxx-&xxxxx;,&xxxxx;,&xxxxx;-x-xxxxxxxxxxxxxxxxx)-2-xxxxxxxxxxxx)-3-(2,6-xxxxxxxxxxxxxxxx)xxxx

417-680-3

101463-69-8

Xxxx.

X362

XXX09

X362

&xxxx;

X = 10 000

M = 10&xxxx;000

&xxxx;

Xxxxxxx Xxxxx 1

X400

Xxx

&xxxx;

Xxxxxxx Chronic 1

X410

&xxxx;

X410

616-207-00-X

polyhexamethylene xxxxxxxxx xxxxxxxxxxxxx

&xxxx;

27083-27-8 xx 32289-58-0

Xxxx. 2

X351

XXX05

X351

 

X = 10

X = 10

 

Xxxxx Xxx. 4

H302

XXX07

X302

STOT RE 1

X372 (xxxxxxxxxxx xxxxx) (xxxxxxxxxx)

XXX08

X372 (xxxxxxxxxxx xxxxx) (xxxxxxxxxx)

Xxx Dam. 1

X318

XXX09

X318

Xxxx Xxxx. 1X

X317

Dgr

H317

Aquatic Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

H410

 

X410

616-208-00-5

X-xxxxx-2-xxxxxxxxxxx;

1-xxxxxxxxxxxxxxx-2-xxx

220-250-6

2687-91-4

Xxxx. 1X

X360X

XXX08

Xxx

X360X

&xxxx;

&xxxx;

&xxxx;

616-209-00-0

xxxxxxxxxxxxx (XXX);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

Xxxxxxx Acute 1

X400

XXX09

&xxxx;

&xxxx;

X = 100

M = 100

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

Xxx

X410

616-210-00-6

xxxxxxxxxxxx (XXX);

X-(4-xxxxxxxxxxxxxxx)-4-xxxxxx-3-xxxxx-1-xxxxxx-1Xxxxxxxxx-5- xxxxxxxxxxx

&xxxx;

119168-77-3

Xxxxx Xxx. 3

X301

GHS06

X301

&xxxx;

X = 10

X = 10

 

Acute Xxx. 4

X332

XXX08

X332

STOT XX 2

X373 (xxxxxxxxxxxxxxxx tract) (Xxxx)

XXX09

X373 (gastrointestinal tract) (Xxxx)

Xxxx Xxxx. 1X

X317

Xxx

X317

Aquatic Xxxxx 1

X400

&xxxx;

&xxxx;

Xxxxxxx Xxxxxxx 1

X410

&xxxx;

X410

616-211-00-1

xxxxxxxxxxx (XXX);

6-xxxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xxx

 

189278-12-4

Xxxx. 2

X351

XXX08

X351

&xxxx;

M = 1

X = 10

&xxxx;

Xxxxxxx Xxxxx 1

H400

XXX09

 

Xxxxxxx Xxxxxxx 1

X410

Xxx

H410

XŘ&Xxxxxx;XXXX XX

Indexové číslo

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx xxxxxxx&xxxxxx;xx látek

Č&xxxxxx;xxx XX

Č&xxxxxx;xxx XXX

Klasifikace

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; limity

Xxxx.

015-004-00-8

xxxxxxxxx xxxxxxxxx

244-088-0

20859-73-8

X; R15/29

X+; X26/28

Xx; X21

X32

X; R50

X; T+; X

X: 15/29-21- 26/28-32-50

X: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

X; X50: X &xx; 0,25&xxxx;%

&xxxx;

015-005-00-3

magnesium phosphide;

xxxxxxxxxxxx xxxxxxxxxxx

235-023-7

12057-74-8

X; R15/29

X+; X26/28

Xn; X21

X32

X; R50

F; X+; X

X: 15/29-21-26/28-32-50

X: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

X; X50: C ≥ 0,25&xxxx;%

&xxxx;

015-123-00-5

xxxxxxxxxx (XXX);

ethyl-4-methylthio-m-tolyl xxxxxxxxx xxxxxxxxxxxxxxx

244-848-1

22224-92-6

X+; X26/28

T; X24

Xx; X36

X; R50-53

X+; X

R: 24-26/28-36-50/53

X: (1/2-)23-26-28-35-36/37-45-60-61

X; R50-53: X &xx; 0,25 %

N; X51-53: 0,025 % ≤ X &xx; 0,25&xxxx;%

R52-53: 0.0025&xxxx;% &xx; C &xx; 0,025&xxxx;%

 

030-012-00-1

xxxxxxxxx-xxxxxxxxx-xxxx-xxxxxxxxx-xxxxxxxxx

423-570-6

169314-88-9

X53

R: 53

X: 61

&xxxx;

&xxxx;

602-006-00-4

xxxxxxxxxx;

xxxxxxxxxxxxxxxx

200-663-8

67-66-3

Xxxx. Xxx. 3; X40

Xxxx. Cat. 3; X63

Xx; X20/22-48/20

Xx; X36/38

Xx

R: 20/22-36/38-40-48/20-63

X: (2-)36/37

 

&xxxx;

603-097-00-3

1,1′,1″-nitrilotripropan-2-ol;

triisopropanolamine

204-528-4

122-20-3

Xi; R36

Xi

X: 36

X: (2-)26

&xxxx;

 

605-008-00-3

xxxxxxxx;

xxxx-2-xxxx;

acrylaldehyde

203-453-4

107-02-8

X; X11

T+; X26/28

X; R24

X; X34

X; X50

X; X+; X

X: 11-24-26/28-34-50

X: (1/2-)23-26-28-36/37/39-45-61

C; X34: X &xx; 0,1&xxxx;%

N; X50: X ≥ 0,25&xxxx;%

X

607-023-00-0

xxxxx xxxxxxx

203-545-4

108-05-4

X; X11

Xxxx. Xxx. 3; R40

Xx; X20

Xx; X37

X; Xx

R: 11-20-37-40

X: 9-16-33-36/37

&xxxx;

D

607-613-00-8

xxxxxxxx mass xx:

&xxxx;

xxxxxxxx xxxx

&xxxx;

xxxxxxxxxxxxxxx xxxx

&xxxx;

dipersuccinic xxxx

&xxxx;

xxxxxxxxxx xxxxx xx xxxxxxxx acid

&xxxx;

xxxxxxxxxx ester xx xxxxxxxxxxx xxxx

&xxxx;

xxxxxxxx xxxxxxxxx

&xxxx;

xxxxxxxx xxxx

 

monoperglutaric xxxx

&xxxx;

xxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx of xxxxxxxx xxxx

 

monomethyl xxxxx xx perglutaric acid

&xxxx;

xxxxxxxx xxxxxxxxx

&xxxx;

xxxxxx acid

&xxxx;

xxxxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxxx xxxx

&xxxx;

xxxxxxxxxx xxxxx xx xxxxxx acid

&xxxx;

monomethyl xxxxx xx peradipic xxxx

 

dimethyl xxxxxxx

&xxxx;

xxxxxxxx xxxxxxxx

 

xxxxxxxx

 

xxxxx

432-790-1

&xxxx;

C; R34

Xx; X20/21/22-68/20/21/22

X

X: 20/21/22-34-68/20/21/22

X: (1/2-)26-28-36/37/39-45

 

 

609-003-00-7

xxxxxxxxxxxx

202-716-0

98-95-3

Carc. Xxx. 3; X40

Xxxx. Xxx. 2; X60

X; X23/24/25-48/23/24/25

X52-53

X

X: 23/24/25-48/23/24/25-40-60-52/53

X: 45-53

&xxxx;

&xxxx;

612-120-00-6

aclonifen (XXX);

2-xxxxxx-6-xxxxx-3-xxxxxxxxxxxxxx

277-704-1

74070-46-5

Xxxx. Xxx. 3; X40

X43

X; X50-53

Xx; X

X: 40-43-50/53

X: (2-)36/37-60-61

X43: X &xx; 0,1 %

X; R50-53: X &xx; 0,25&xxxx;%

N; X51-53: 0,025&xxxx;% &xx; X < 0,25 %

X52-53: 0,0025&xxxx;% &xx; X &xx; 0,025&xxxx;%

 

613-175-00-9

xxxxxxxxxxxxx (ISO);

(2XX,3XX)-3-(2-xxxxxxxxxxxx)-2-(4-xxxxxxxxxxxx)-[(1X-1,2,4-xxxxxxx-1-xx)xxxxxx]xxxxxxx

406-850-2

133855-98-8

Xxxx. Xxx. 3; R40

Xxxx. Xxx. 2; X61

Repr. Xxx. 3; X62

X; X51-53

X; X

X: 61-40-62-51/53

X: 45-53-61

&xxxx;

&xxxx;

616-200-00-1

xxxxxxxx xxxx xx X,X&xxxxx;-xxxxxx-1,2-xxxxxxx(xxxxxxxxxx) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide xxx N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)

432-430-3

 

R53

X: 53

X: 61

&xxxx;

&xxxx;

648-055-00-5

xxxxx, xxxx xxx, high-temp.;

[Xxx residue xxxx xxx xxxxxxxxxxxx xx xxxx xxxxxxxxxxx xxxx tar. X xxxxx xxxxx xxxx xx xxxxxxxxxxx xxxxxxxxx xxxxx xxxx 30&xxxx;&xxx;X xx 180&xxxx;&xxx;X (86&xxxx;&xxx;X xx 356&xxxx;&xxx;X). Composed xxxxxxxxx xx x xxxxxxx xxxxxxx xx xxxxx xx xxxx xxxxxxxx xxxxxxxxx xxxx xxxxxxxx xxxxxxxxxxxx.]

266-028-2

65996-93-2

Xxxx. Xxx. 1; X45

Muta. Xxx. 2; X46

Repr. Xxx. 2; X60-61

N; R50-53

X; X

X: 45-46-60-61-50/53

X: 45-53-60-61

X; X50-53: C ≥ 0,025&xxxx;%

X; X51-53: 0,0025 % &xx; C &xx;

0,025 %

R52-53: 0,00025&xxxx;% ≤ X &xx;

0,0025&xxxx;%

&xxxx;

649-330-00-2

xxxxxxx (xxxxxxxxx), hydrodesulphurized xxxxx;

Xxx boiling point xxxxxxxx treated xxxxxxx;

[X xxxxxxx xxxxxxxxxxx xx xxxxxxxxxxxx xxxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxx. It xxxxxxxx xx xxxxxxxxxxxx xxxxxx xxxxxx xxxxxxx predominantly xx the xxxxx xx X7 xxxxxxx X12 and xxxxxxx xx xxx xxxxx xx approximately 90&xxxx;&xxx;X xx 230 °C (194&xxxx;&xxx;X xx 446&xxxx;&xxx;X).]

265-185-4

64742-82-1

Carc. Cat. 2; X45

Xxxx. Xxx. 2; X46

Xx; X48/20-65

X

X: 45-46-48/20-65

X: 45-53

&xxxx;

X

649-345-00-4

xxxxxxxx xxxxxxx;

Xxx xxxxxxx xxxxx naphtha &xxxxx; unspecified;

[X xxxxxxxxxx, xxxxxxx xxxxxxxxx xxxxxxxxxx xxxx is xxxx xxxx xxxxxx xx xxxxxxxxxxxxx xxxxxx xxx xxxx xxxxx in x range xx xxxxxxxxxxxxx 148,8&xxxx;&xxx;X to 204,4&xxxx;&xxx;X (300 °F xx 400&xxxx;&xxx;X).]

232-489-3

8052-41-3

Xxxx. Xxx. 2; X45

Muta. Xxx. 2; X46

Xn; X48/20-65

X

R: 45-46-48/20-65

X: 45-53

 

P

649-405-00-X

xxxxxxx xxxxxxx (xxxxxxxxx), xxxxxx xxxxx.;

Xxxxxxxx xxx xxxxxxxx;

[A xxxxxxx xxxxxxxxxxx xx hydrocarbons xxxxxxxx from xxx xxxxxxxxxxxx of crude xxx xx xxxxxxx xxxxxxxx. Xx xxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx having xxxxxx xxxxxxx predominantly xx xxx xxxxx xx X9 through X12 xxx boiling xx xxx xxxxx of xxxxxxxxxxxxx 140&xxxx;&xxx;X to 220&xxxx;&xxx;X (284&xxxx;&xxx;X xx 428&xxxx;&xxx;X).]

265-191-7

64742-88-7

Xx; X48/20-65

Xx

X: 48/20-65

X: (2-)23-24-62

&xxxx;

&xxxx;

XŘ&Xxxxxx;XXXX V

Indexové č&xxxxxx;xxx

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx chemických x&xxxxxx;xxx

Č&xxxxxx;xxx XX

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Xxxx.

031-001-00-4

xxxxxxx xxxxxxxx

215-114-8

1303-00-0

Xxxx. Xxx. 2; X45

X; X48/23

X

R: 45-48/23

X: 45-53

&xxxx;

X

050-025-00-6

xxxxxxxxxxxxxxxxxxxxxxx

213-608-8

993-16-8

Xxxx. Xxx. 3; X63

Xx

X: 63

X: (2-)22-36/37

 

&xxxx;

050-026-00-1

2-xxxxxxxxxx 10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

260-828-5

57583-34-3

Xxxx. Xxx. 3; X63

Xx

X: 63

X: (2-)22-36/37

 

 

050-027-00-7

2-ethylhexyl 10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxxx

239-622-4

15571-58-1

Xxxx. Xxx. 2; X61

X

X: 61

S: 45-53

&xxxx;

&xxxx;

601-087-00-3

2,4,4-xxxxxxxxxxxxxxxx

246-690-9

25167-70-8

X; X11

Xx; X65

X67

F; Xn

X: 11-65-67

X: 9-16-33-62

&xxxx;

X

606-145-00-1

sulcotrione (XXX);

2-[2-xxxxxx-4-(xxxxxxxxxxxxxx)xxxxxxx]xxxxxxxxxxx-1,3-xxxxx

&xxxx;

99105-77-8

Xxxx. Xxx. 3; X63

Xx; X48/22

X43

X; X50-53

Xx; X

X: 43-48/22-63-50/53

X: (2-)22-36/37-60-61

X; X50-53: X &xx; 25 %

X; X51-53: 2,5&xxxx;% &xx; X &xx; 25&xxxx;%

R52-53: 0,25&xxxx;% ≤ X&xx; 2,5&xxxx;%

X43: X &xx; 0,1&xxxx;%

&xxxx;

607-699-00-7

xxxxxxxxxx (ISO);

(2-xxxxxxxxxxxxxx-3-xx)xxxxxx xxx-(1X,3X)-3-[(1X)-2-xxxxxx-3,3,3-xxxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

&xxxx;

82657-04-3

Xxxx. Xxx 3; X40

X; X23/25

Xx; X48/22

X43

X; X50-53

X; X

X: 23/25-40-43-48/22-50/53

X: (1/2-)23-24-36/37-38- 45-60-61

X; X50-53: X &xx; 0,0025&xxxx;%

N; R51-53: 0,00025&xxxx;% ≤ X&xx; 0,0025&xxxx;%

X52-53: 0,000025 % &xx; X &xx; 0,00025&xxxx;%

&xxxx;

607-700-00-0

indoxacarb (XXX);

xxxxxx (4xX)-7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx

&xxxx;

173584-44-6

X; X25-48/25

Xx; X20

X43

X; R50-53

X; N

X: 20-25-43-48/25-50/53

X: (1/2-)24-37-45-60-61

X; X50-53: X &xx; 25 %

X; X51-53: 2,5&xxxx;% &xx; X &xx; 25&xxxx;%

R52-53: 0,25&xxxx;% &xx; X &xx; 2,5 %

&xxxx;

607-701-00-6

xxxxxxxx mass xx (X)- Indoxacarb xxx (X)- Xxxxxxxxxx 75:25;

xxxxxx 7-xxxxxx-2-{(xxxxxxxxxxxxxxx)[4-(xxxxxxxxxxxxxxxx)xxxxxx]xxxxxxxxx}-2,5-xxxxxxxxxxxxx[1,2-x][1,3,4]xxxxxxxxxx-4x(3X)-xxxxxxxxxxx

&xxxx;

144171-61-9

X; R48/25

Xn; X20/22

X43

X; X50-53

X; N

X: 20/22-43-48/25-50/53

X: (1/2-)24-37-45-60-61

N; X50-53: X &xx; 25&xxxx;%

N; X51-53: 2,5&xxxx;% &xx; X &xx; 25&xxxx;%

X52-53: 0,25&xxxx;% &xx; C &xx; 2,5&xxxx;%

 

607-702-00-1

xxxxxxx phthalate

201-559-5

84-75-3

Repr. Xxx. 2; X60-61

X

X: 60-61

X: 45-53

&xxxx;

&xxxx;

607-703-00-7

ammoniumpentade- xxxxxxxxxxxxxxxxx

223-320-4

3825-26-1

Xxxx. Xxx. 3; X40

Xxxx. Xxx. 2; R61

X64

T; X48/23

Xx; X20/22-48/21/22

Xx; R41

X

X: 61-20/22-40-41- 48/23-48/21/22-64

X: 45-53

&xxxx;

 

607-704-00-2

xxxxxxxxxxxxxxxxx xxxx

206-397-9

335-67-1

Xxxx. Xxx. 3; X40

Xxxx. Xxx. 2; X61

X64

X; R48/23

Xx; R20/22-48/21/22

Xi; X41

X

X: 61-20/22-40-41-48/23-48/21/22-64

S: 45-53

&xxxx;

&xxxx;

612-282-00-8

octadecylamine

204-695-3

124-30-1

Xx; X48/22-65

Xx; X38-41

X; X50-53

Xx; X

X: 38-41-48/22-65-50/53

S: (2-)26-36/37/39-60-61-62

X; X50-53: X ≥ 2,5&xxxx;%

X; X51-53: 0,25&xxxx;% &xx; X < 2,5&xxxx;%

X52-53: 0,025&xxxx;% &xx; X &xx; 0,25&xxxx;%

 

612-283-00-3

(X)-xxxxxxx-9-xxxxxxxxx

204-015-5

112-90-3

Xn; X22-48/22-65

X; X34

N; X50-53

X; X

X: 22-34-48/22-65-50/53

X: (1/2-)23-26-36/37/39-45-60-61-62

X; X34: C ≥ 10&xxxx;%

Xx; X36/37/38: 5 % &xx; X &xx; 10&xxxx;%

X; X50-53: C &xx; 2,5&xxxx;%

X; X51-53: 0,25&xxxx;% ≤ C &xx; 2,5&xxxx;%

X52-53: 0,025&xxxx;% &xx; C &xx; 0,25&xxxx;%

&xxxx;

612-284-00-9

xxxxxx, xxxxxxxxxxxx tallow xxxxx

262-976-6

61788-45-2

Xx; X48/22-65

Xx; R38-41

X; X50-53

Xx; X

X: 38-41-48/22-65-50/53

X: (2-)26-36/37/39-60-61-62

X; X50-53: X &xx; 2,5&xxxx;%

X; X51-53: 0,25&xxxx;% &xx; X &xx; 2,5&xxxx;%

R52-53: 0,025&xxxx;% &xx; C &xx; 0,25&xxxx;%

&xxxx;

612-285-00-4

xxxxxx, xxxx alkyl

262-977-1

61788-46-3

Xx; X22-48/22-65

X; X35

N; X50-53

X; X

X: 22-35-48/22-65-50/53

S: (1/2-)23-26-36/37/39-45-60-61-62

X; X35: C &xx; 10&xxxx;%

X; R34: 5&xxxx;% &xx; C &xx; 10&xxxx;%

Xx; R36/37/38: 1&xxxx;% &xx; C < 5&xxxx;%

X; X50-53: X &xx; 2,5&xxxx;%

X; R51-53: 0,25&xxxx;% &xx; C &xx; 2,5&xxxx;%

X52-53: 0,025 % &xx; X &xx; 0,25&xxxx;%

&xxxx;

612-286-00-X

xxxxxx, tallow xxxxx

263-125-1

61790-33-8

Xx; X22-48/22-65

X; X35

N; 50-53

X; X

X: 22-35-48/22-65-50/53

S: (1/2-)26-36/37/39-45-60-61-62

N; X50-53: X &xx; 2,5&xxxx;%

X; R51-53: 0,25&xxxx;% &xx; C &xx; 2,5&xxxx;%

X52-53: 0,025&xxxx;% &xx; X < 0,25&xxxx;%

&xxxx;

616-206-00-4

xxxxxxxxxxxx (XXX);

1-(4-(2-xxxxx-&xxxxx;,&xxxxx;,&xxxxx;-x-xxxxxxxxxxxxxxxxx)-2-xxxxxxxxxxxx)-3-(2,6-xxxxxxxxxxxxxxxx)xxxx

417-680-3

101463-69-8

X64

X33

X; X50-53

N

R: 33-64-50/53

S: (2-)22-36/37-46-60-61

X; X50-53&xxxx;X ≥ 0,0025&xxxx;%

X; X51-53 0,00025 % &xx; C &xx; 0,0025&xxxx;%

X52-53 0,000025 % &xx; X &xx; 0,00025 %

&xxxx;

616-207-00-X

xxxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxxxxxx

&xxxx;

27083-27-8 xx 32289-58-0

Xxxx. Cat 3; X40

Xx; X22

X; X48/23

Xx; X41

X43

X; R50-53

X; N

X: 22-40-41-43-48/23-50/53

X: (1/2-)22-36/37/39-45-60-61

X; X50-53: X ≥ 2,5&xxxx;%

N; X51-53: 0,25 % &xx; X < 2,5

X52-53: 0,025&xxxx;% ≤ X &xx; 0,25&xxxx;%

 

616-208-00-5

X-xxxxx-2-xxxxxxxxxxx;

1-ethylpyrrolidin-2-one

220-250-6

2687-91-4

Xxxx. Xxx. 2; X61

T

X: 61

X: 45-53

&xxxx;

&xxxx;

616-209-00-0

xxxxxxxxxxxxx (XXX);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

N; X50-53

N

R: 50/53

X: 60-61

N; R50-53: X &xx; 0,25&xxxx;%

X; X51-53: 0,025&xxxx;% &xx; X < 0,25&xxxx;%

R52-53: 0,0025&xxxx;%&xx; X &xx; 0,025&xxxx;%

&xxxx;

616-210-00-6

xxxxxxxxxxxx (XXX);

X-(4-xxxxxxxxxxxxxxx)-4-xxxxxx-3-xxxxx-1-xxxxxx-1Xxxxxxxxx-5- xxxxxxxxxxx

&xxxx;

119168-77-3

Xx; X20/22

X43

X; X50-53

Xx; N

R: 20/22-43-50/53

X: (2-)24-37-46-60-61

N; X50-53: X &xx; 2,5&xxxx;%

X; X51-53: 0,25&xxxx;% &xx; X < 2,5&xxxx;%

R52-53: 0,025&xxxx;% &xx; X &xx; 0,25&xxxx;%

 

616-211-00-1

proquinazid (XXX);

6-xxxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xxx

 

189278-12-4

Carc. Xxx. 3; R40

X; X50-53

Xx; X

X: 40-50/53

X: (2-)36/37-46-60-61

&xxxx;

&xxxx;